Be part of our Research

News

Patient-Derived Brain Tumour iPSCs: Models for Investigating Glioma Stemness & Drug Discovery

May 8th 2018

Gliomas are incurable brain cancers. Dysregulated, stem cell-like self-renewal has been implicated in glioma treatment resistance and tumour recurrence. Drugs that eliminate tumour cells possessing this malignant characteristic are urgently needed. It remains, however, an experimental challenge to link heterogeneous glioma genotypes to drug response at scale.

Read
News

Censo Biotechnologies attending Cancer Research UK's inaugural Brain Tumour Conference

April 30th 2018

Cancer Research UK's Brain Tumour Conference will unite the brightest minds in cancer research to discuss and debate some of the greatest issues in the field. The multidisciplinary programme combines expertise from across the breadth of brain tumour research, together with insights from allied disciplines, to spark new opportunities for collaborative research.

Read
News

iPSC-derived Cortical Neuronal High Content Assay

April 17th 2018

Induced pluripotent stem cell (iPSC) technology is used to produce cortical neurons and facilitates physiologically relevant disease modelling and drug discovery. Our poster describes our robust methodology to produce, characterise and assay cortical neurons.

Read
News

The Patient Derived iPSCs for High Grade Glioma (PDi:HGG) project

March 12th 2018

The Patient Derived iPSCs for High Grade Glioma (PDi:HGG) project, supported by Innovate UK and in participation with the University of Leeds, will provide a new strategy for researchers to develop treatments specifically for this cancer.

Read
News

Innovation Recognition for Censo Biotechnologies at SLAS2018

February 1st 2018

Censo Biotechnologies is one of eight companies selected to exhibit on 'Innovation AveNEW' at SLAS2018 in San Diego from 3 - 7 February.

Read
News

Censo Biotechnologies to present at Late Night with LRIG

January 12th 2018

Simon MacKenzie, Chief Business Officer, will be presenting 'Assessing patient population therapeutic response variability using human iPSC derived microglia' at Late Night with LRIG, part of SLAS2018.

Read
News

Censo Biotechnology awarded SMART funding to develop new stem cell technology

November 21st 2017

Censo Biotechnologies Ltd. (“Censo”) announced today that it has been awarded a Scottish Enterprise SMART:SCOTLAND grant to undertake an innovation project that will develop new methods to create stem cells for medical research.

Read
News

Sharing research, developing partnerships

November 14th 2017

Censo Biotechnologies has been on the exhibition trail over the last few weeks attending some key industry events to present posters, highlight the company's iPSC services and to meet up with colleagues and potential partners.

Read
News

Human iPSC derived Microglia-like cells

October 19th 2017

Microglia are the tissue resident macrophage of the brain. Our poster, presented at ELRIG Drug Discovery 2017, describes Censo’s human Microglia-like cell characterisation and how these cells, which are available for clients, can be a useful tool in drug discovery projects.

Read
News

Presentation: Humanized Phenotypic Screening Platform for Chronic Pain

August 21st 2017

In case you missed our Webinar... We now have a presentation available, in conjunction with Cellectricon, of a first in kind fully humanized screening platform that enables clients to make the best decisions on which compounds to advance to the clinic.

Read
News